These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26986213)

  • 21. In utero injection of alpha-L-iduronidase-carrying retrovirus in canine mucopolysaccharidosis type I: infection of multiple tissues and neonatal gene expression.
    Meertens L; Zhao Y; Rosic-Kablar S; Li L; Chan K; Dobson H; Gartley C; Lutzko C; Hopwood J; Kohn D; Kruth S; Hough MR; Dubé ID
    Hum Gene Ther; 2002 Oct; 13(15):1809-20. PubMed ID: 12396614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Architecture of the canine IDUA gene and mutation underlying canine mucopolysaccharidosis I.
    Menon KP; Tieu PT; Neufeld EF
    Genomics; 1992 Nov; 14(3):763-8. PubMed ID: 1339393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzyme replacement therapy with laronidase (Aldurazyme) for treating mucopolysaccharidosis type I.
    Jameson E; Jones S; Wraith JE
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009354. PubMed ID: 24085657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic analysis of mucopolysaccharidosis I mouse brain with two-dimensional polyacrylamide gel electrophoresis.
    Ou L; Przybilla MJ; Whitley CB
    Mol Genet Metab; 2017; 120(1-2):101-110. PubMed ID: 27742266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corneal opacity in canine MPS I. Changes after bone marrow transplantation.
    Constantopoulos G; Scott JA; Shull RM
    Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1802-7. PubMed ID: 2503461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients.
    Matte U; Yogalingam G; Brooks D; Leistner S; Schwartz I; Lima L; Norato DY; Brum JM; Beesley C; Winchester B; Giugliani R; Hopwood JJ
    Mol Genet Metab; 2003 Jan; 78(1):37-43. PubMed ID: 12559846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal Systemic AAV Induces Tolerance to CNS Gene Therapy in MPS I Dogs and Nonhuman Primates.
    Hinderer C; Bell P; Louboutin JP; Zhu Y; Yu H; Lin G; Choa R; Gurda BL; Bagel J; O'Donnell P; Sikora T; Ruane T; Wang P; Tarantal AF; Casal ML; Haskins ME; Wilson JM
    Mol Ther; 2015 Aug; 23(8):1298-1307. PubMed ID: 26022732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of neuropathology in mucopolysaccharidosis I patients.
    Fuller M; Brooks DA; Evangelista M; Hein LK; Hopwood JJ; Meikle PJ
    Mol Genet Metab; 2005 Jan; 84(1):18-24. PubMed ID: 15639191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I.
    Belur LR; Temme A; Podetz-Pedersen KM; Riedl M; Vulchanova L; Robinson N; Hanson LR; Kozarsky KF; Orchard PJ; Frey WH; Low WC; McIvor RS
    Hum Gene Ther; 2017 Jul; 28(7):576-587. PubMed ID: 28462595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction of clinical manifestations of canine mucopolysaccharidosis I with neonatal retroviral vector gene therapy.
    Traas AM; Wang P; Ma X; Tittiger M; Schaller L; O'donnell P; Sleeper MM; Vite C; Herati R; Aguirre GD; Haskins M; Ponder KP
    Mol Ther; 2007 Aug; 15(8):1423-31. PubMed ID: 17519893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Craniofacial abnormalities in a murine knock-out model of mucopolysaccharidosis I H: a computed tomography and anatomic study.
    Graupman P; Pan D; Konair B; Hartung S; McIvor S; Whitley C; Low W; Lam CH
    J Craniofac Surg; 2004 May; 15(3):392-8. PubMed ID: 15111796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system.
    Schuh RS; Poletto É; Pasqualim G; Tavares AMV; Meyer FS; Gonzalez EA; Giugliani R; Matte U; Teixeira HF; Baldo G
    J Control Release; 2018 Oct; 288():23-33. PubMed ID: 30170069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow transplantation in canine mucopolysaccharidosis I. Effects within the central nervous system.
    Shull RM; Hastings NE; Selcer RR; Jones JB; Smith JR; Cullen WC; Constantopoulos G
    J Clin Invest; 1987 Feb; 79(2):435-43. PubMed ID: 3100576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffusion tensor imaging and myelin composition analysis reveal abnormal myelination in corpus callosum of canine mucopolysaccharidosis I.
    Provenzale JM; Nestrasil I; Chen S; Kan SH; Le SQ; Jens JK; Snella EM; Vondrak KN; Yee JK; Vite CH; Elashoff D; Duan L; Wang RY; Ellinwood NM; Guzman MA; Shapiro EG; Dickson PI
    Exp Neurol; 2015 Nov; 273():1-10. PubMed ID: 26222335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcranial pulsed ultrasound facilitates brain uptake of laronidase in enzyme replacement therapy for Mucopolysaccharidosis type I disease.
    Hsu YH; Liu RS; Lin WL; Yuh YS; Lin SP; Wong TT
    Orphanet J Rare Dis; 2017 Jun; 12(1):109. PubMed ID: 28595620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canine alpha-L-iduronidase deficiency. A model of mucopolysaccharidosis I.
    Shull RM; Munger RJ; Spellacy E; Hall CW; Constantopoulos G; Neufeld EF
    Am J Pathol; 1982 Nov; 109(2):244-8. PubMed ID: 6215865
    [No Abstract]   [Full Text] [Related]  

  • 37. Patient iPSC-derived neural stem cells exhibit phenotypes in concordance with the clinical severity of mucopolysaccharidosis I.
    Swaroop M; Brooks MJ; Gieser L; Swaroop A; Zheng W
    Hum Mol Genet; 2018 Oct; 27(20):3612-3626. PubMed ID: 30052969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosing lysosomal storage disorders: mucopolysaccharidosis type I.
    Johnson BA; Dajnoki A; Bodamer OA
    Curr Protoc Hum Genet; 2015 Jan; 84():17.17.1-17.17.8. PubMed ID: 25599668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
    Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
    Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trehalose reduces retinal degeneration, neuroinflammation and storage burden caused by a lysosomal hydrolase deficiency.
    Lotfi P; Tse DY; Di Ronza A; Seymour ML; Martano G; Cooper JD; Pereira FA; Passafaro M; Wu SM; Sardiello M
    Autophagy; 2018; 14(8):1419-1434. PubMed ID: 29916295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.